Back to Search
MICHAEL RIEL, PHARMD
PHARMD
Pharmacist
NPI: 1881327377Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
86212(CA)
Research & Publications (5)
A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers.
PMID 19635898·Am J Trop Med Hyg·2009
2-rct
Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
PMID 16256090·Chem Biol Interact·2005
8-other
Efficacy of proton pump inhibitor drugs against Plasmodium falciparum in vitro and their probable pharmacophores.
PMID 12121943·Antimicrob Agents Chemother·2002
7-preclinical
Efficacy of scopadulcic acid A against Plasmodium falciparum in vitro.
PMID 11975516·J Nat Prod·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1101 FRESNO ST
FRESNO, CA 93706 - Phone
- (559) 575-4363
Quick Facts
- NPI
- 1881327377
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile